Lipitor Generics Could Come 15 Months Earlier Than Anticipated After Patent Deemed Invalid
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer says “technical defect” in patent could be corrected with U.S. Patent and Trademark Office.